Merck (MRK) Reports In-Line Q4 EPS; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Merck (MRK) PT Raised to $132 at BofA Securities
February 4, 2026 5:48 AM ESTBofA Securities analyst Tim Anderson raised the price target on Merck (NYSE: MRK) to $132.00 (from $124.00) while maintaining a Buy rating.
The analyst comments "Post 4Q, we reduce our MRK 2026 sales and EPS to reflect greater conservatism around some LOE products, US... More
